Chronic myelogenous leukemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
| Line 16: | Line 16: | ||
*[[Acute myeloid leukemia]] | *[[Acute myeloid leukemia]] | ||
*[[Thrombocytosis]] | *[[Thrombocytosis]] | ||
==References== | ==References== | ||
Revision as of 13:55, 21 July 2017
|
Chronic myelogenous leukemia Microchapters |
|
Differentiating Chronic myelogenous leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic myelogenous leukemia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Chronic myelogenous leukemia differential diagnosis |
|
Chronic myelogenous leukemia differential diagnosis in the news |
|
Blogs on Chronic myelogenous leukemia differential diagnosis |
|
Directions to Hospitals Treating Chronic myelogenous leukemia |
|
Risk calculators and risk factors for Chronic myelogenous leukemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Chronic myelogenous leukemia must be differentiated from leukemoid reaction, chronic neutrophilic leukemia, and acute myeloid leukemia.[1]
Differential Diagnosis
Chronic myelogenous leukemia must be differentiated from:[1][2][3]
- Leukemoid reaction associated with:
- High leukocyte alkaline phosphatase
- White blood cell counts lower than 50 × 10^9/L
- Döhle's bodies in the granulocytes
- Absence of basophilia
- Basophils and eosinophils are almost always increased in chronic myelogenous leukemia
References
- ↑ 1.0 1.1 Gajendra S, Gupta R, Chandgothia M, Kumar L, Gupta R, Chavan SM (2014). "Chronic Neutrophilic Leukemia with V617F JAK2 Mutation". Indian J Hematol Blood Transfus. 30 (2): 139–42. doi:10.1007/s12288-012-0203-6. PMC 4022913. PMID 24839370.
- ↑ Kanegae MP, Ximenes VF, Falcão RP, Colturato VA, de Mattos ER, Brunetti IL; et al. (2007). "Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay". J Clin Lab Anal. 21 (2): 91–6. doi:10.1002/jcla.20140. PMID 17385676.
- ↑ Jabbour E, Kantarjian H (2014). "Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management". Am J Hematol. 89 (5): 547–56. doi:10.1002/ajh.23691. PMID 24729196.